468 related articles for article (PubMed ID: 22429962)
1. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
[TBL] [Abstract][Full Text] [Related]
2. The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Tormo AJ; Letellier MC; Lissilaa R; Batraville LA; Sharma M; Ferlin W; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Dec; 60(3):653-60. PubMed ID: 22986012
[TBL] [Abstract][Full Text] [Related]
3. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
4. PD-1 up-regulation on CD4
Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
6. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-Like Factor 1, an Essential Facilitator of Cardiotrophin-Like Cytokine:Ciliary Neurotrophic Factor Receptor α Signaling and sorLA-Mediated Turnover.
Larsen JV; Kristensen AM; Pallesen LT; Bauer J; Vægter CB; Nielsen MS; Madsen P; Petersen CM
Mol Cell Biol; 2016 Apr; 36(8):1272-86. PubMed ID: 26858303
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
9. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.
Akram KM; Lomas NJ; Forsyth NR; Spiteri MA
Int J Clin Exp Pathol; 2014; 7(2):552-64. PubMed ID: 24551275
[TBL] [Abstract][Full Text] [Related]
10. The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis.
Yombo DJK; Odayar V; Gupta N; Jegga AG; Madala SK
Front Immunol; 2021; 12():645717. PubMed ID: 33815402
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
12. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality.
Yue X
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):560-569. PubMed ID: 28657777
[TBL] [Abstract][Full Text] [Related]
14. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.
Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221
[TBL] [Abstract][Full Text] [Related]
15. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
Varma S; Mahavadi P; Sasikumar S; Cushing L; Hyland T; Rosser AE; Riccardi D; Lu J; Kalin TV; Kalinichenko VV; Guenther A; Ramirez MI; Pardo A; Selman M; Warburton D
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L405-19. PubMed ID: 24375798
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
17. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
18. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.
Reilkoff RA; Peng H; Murray LA; Peng X; Russell T; Montgomery R; Feghali-Bostwick C; Shaw A; Homer RJ; Gulati M; Mathur A; Elias JA; Herzog EL
Am J Respir Crit Care Med; 2013 Jan; 187(2):180-8. PubMed ID: 23220917
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.
Yu G; Kovkarova-Naumovski E; Jara P; Parwani A; Kass D; Ruiz V; Lopez-Otín C; Rosas IO; Gibson KF; Cabrera S; Ramírez R; Yousem SA; Richards TJ; Chensny LJ; Selman M; Kaminski N; Pardo A
Am J Respir Crit Care Med; 2012 Oct; 186(8):752-62. PubMed ID: 22859522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
